N-(4-chloro-3-(trifluoromethyl)benzyl)-3-(1-((2-((4-methylpiperazin-1-yl)amino)pyridin-4-yl)oxy)ethyl)benzamide

ID: ALA4173466

PubChem CID: 141482477

Max Phase: Preclinical

Molecular Formula: C27H29ClF3N5O2

Molecular Weight: 548.01

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(Oc1ccnc(NN2CCN(C)CC2)c1)c1cccc(C(=O)NCc2ccc(Cl)c(C(F)(F)F)c2)c1

Standard InChI:  InChI=1S/C27H29ClF3N5O2/c1-18(38-22-8-9-32-25(16-22)34-36-12-10-35(2)11-13-36)20-4-3-5-21(15-20)26(37)33-17-19-6-7-24(28)23(14-19)27(29,30)31/h3-9,14-16,18H,10-13,17H2,1-2H3,(H,32,34)(H,33,37)

Standard InChI Key:  VWINXVFVVLWUGN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
   28.6044  -21.3006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6033  -22.1243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3154  -22.5373    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.0292  -22.1238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0264  -21.2970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3136  -20.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7417  -22.5354    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.7430  -23.3567    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.3112  -20.0745    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0177  -19.6638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0153  -18.8467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7266  -20.0703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7269  -20.8849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4350  -21.2913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1424  -20.8805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1374  -20.0591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4287  -19.6564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8424  -19.6459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5528  -20.0499    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.8371  -18.8287    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.5581  -20.8671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2684  -21.2711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2709  -22.0859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9804  -22.4898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6865  -22.0765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6785  -21.2552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9684  -20.8549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3973  -22.4796    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   30.0294  -23.7636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0287  -24.5814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7388  -24.9948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.4512  -24.5842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4536  -23.7603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7370  -25.8119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9854  -23.3070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2801  -23.7198    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.6955  -23.7113    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   34.9783  -24.1237    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 16 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 25 28  1  0
  8 29  1  0
  8 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 31 34  1  0
 24 35  1  0
 35 36  1  0
 35 37  1  0
 35 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4173466

    ---

Associated Targets(Human)

HCC78 (247 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H3122 (436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ROS1 Tclin Proto-oncogene tyrosine-protein kinase ROS (2436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALK Tclin ALK tyrosine kinase receptor (7132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 548.01Molecular Weight (Monoisotopic): 547.1962AlogP: 5.40#Rotatable Bonds: 8
Polar Surface Area: 69.73Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 12.80CX LogP: 4.94CX LogD: 3.45
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.39Np Likeness Score: -1.45

References

1. Tian Y, Zhang T, Long L, Li Z, Wan S, Wang G, Yu Y, Hou J, Wu X, Zhang J..  (2018)  Design, synthesis, biological evaluation and molecular modeling of novel 2-amino-4-(1-phenylethoxy) pyridine derivatives as potential ROS1 inhibitors.,  143  [PMID:29174814] [10.1016/j.ejmech.2017.11.002]

Source